Local effects of antimuscarinics
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Masuda, Hitoshi | - |
dc.contributor.author | Kim, Yong-Tae | - |
dc.contributor.author | Tyagi, Shachi | - |
dc.contributor.author | Chancellor, Michael B. | - |
dc.contributor.author | de Miguel, Fernando | - |
dc.contributor.author | Yoshimura, Naoki | - |
dc.date.accessioned | 2022-12-21T09:53:34Z | - |
dc.date.available | 2022-12-21T09:53:34Z | - |
dc.date.created | 2022-09-16 | - |
dc.date.issued | 2006-11 | - |
dc.identifier.issn | 0094-0143 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/180766 | - |
dc.description.abstract | Overactive bladder (OAB) syndrome has been estimated to occur in nearly 17% of the population. The most common drug treatments for OAB are antimuscarinic agents that act to increase bladder capacity and decrease the urge to urinate during the storage phase. An increasing number of studies have focused on the role and mechanism of muscarinic acetylcholine receptors for the regulation of afferent activity during urine storage. Interactions between muscarinic receptors in the urothelium, afferent nerves, or myofibroblasts and locally released acetylcholine might be involved in the emergence of detrusor overactivity and OAB. Therefore, antimuscarinic agents may be effective in treating OAB not only by suppression of muscarinic receptor-mediated detrusor muscle contractions but also by modulation of muscarinic receptor-bladder afferent interactions. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | W B SAUNDERS CO-ELSEVIER INC | - |
dc.title | Local effects of antimuscarinics | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Yong-Tae | - |
dc.identifier.doi | 10.1016/j.ucl.2006.06.011 | - |
dc.identifier.scopusid | 2-s2.0-33749019455 | - |
dc.identifier.wosid | 000241509600012 | - |
dc.identifier.bibliographicCitation | UROLOGIC CLINICS OF NORTH AMERICA, v.33, no.4, pp.511 - + | - |
dc.relation.isPartOf | UROLOGIC CLINICS OF NORTH AMERICA | - |
dc.citation.title | UROLOGIC CLINICS OF NORTH AMERICA | - |
dc.citation.volume | 33 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 511 | - |
dc.citation.endPage | + | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Urology & Nephrology | - |
dc.relation.journalWebOfScienceCategory | Urology & Nephrology | - |
dc.subject.keywordPlus | MUSCARINIC RECEPTOR SUBTYPES | - |
dc.subject.keywordPlus | INTRAVESICAL OXYBUTYNIN | - |
dc.subject.keywordPlus | OVERACTIVE BLADDER | - |
dc.subject.keywordPlus | MUSCLE CONTRACTILITY | - |
dc.subject.keywordPlus | MEDIATE CONTRACTION | - |
dc.subject.keywordPlus | INDUCED CYSTITIS | - |
dc.subject.keywordPlus | PIG BLADDER | - |
dc.subject.keywordPlus | GUINEA-PIG | - |
dc.subject.keywordPlus | DETRUSOR | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/abs/pii/S0094014306000711?via%3Dihub | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.